Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.56B |
| 2 |
Broadcom
AVGO
|
+$441M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$281M |
| 4 |
NVIDIA
NVDA
|
+$278M |
| 5 |
Microsoft
MSFT
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$2.05B |
| 2 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$1.6B |
| 3 |
Lennox International
LII
|
+$284M |
| 4 |
Itaú Unibanco
ITUB
|
+$247M |
| 5 |
Intuit
INTU
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Financials | 19.13% |
| 3 | Healthcare | 9.52% |
| 4 | Industrials | 9.41% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Prologis
PLD
$133B
| $2.16M | ﹤0.01% |
16,891
+2,311
| +16% | +$288K |
|
552
BioMarin Pharmaceuticals
BMRN
$12.3B
| $2.1M | ﹤0.01% |
35,290
+3,564
| +11% | +$194K |
|
553
L3Harris
LHX
$53.4B
| $2.08M | ﹤0.01% |
7,071
+4,310
| +156% | +$1.25M |
|
|
CFLT
554
DELISTED
Confluent
CFLT
| $2.07M | ﹤0.01% |
+68,545
| New | +$1.68M |
|
555
Western Digital
WDC
$150B
| $2.07M | ﹤0.01% |
+11,991
| New | +$1.82M |
|
556
Roper Technologies
ROP
$39.8B
| $2.05M | ﹤0.01% |
4,597
-501
| -10% | -$232K |
|
557
Mizuho Financial
MFG
$130B
| $2.04M | ﹤0.01% |
278,709
-750
| -0.3% | -$5.13K |
|
558
Synchrony
SYF
$25.6B
| $2.01M | ﹤0.01% |
24,076
+376
| +2% | +$28.7K |
|
559
Build-A-Bear
BBW
$462M
| $2M | ﹤0.01% |
32,664
-1,715
| -5% | -$93.3K |
|
560
iShares Semiconductor ETF
SOXX
$48.7B
| $1.99M | ﹤0.01% |
6,618
-356
| -5% | -$105K |
|
561
QCR Holdings
QCRH
$1.7B
| $1.98M | ﹤0.01% |
23,762
-2,618
| -10% | -$206K |
|
|
CPRX
562
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.93M | ﹤0.01% |
82,832
-305
| -0.4% | -$6.79K |
|
563
KeyCorp
KEY
$24.4B
| $1.9M | ﹤0.01% |
92,199
-2,246
| -2% | -$41.8K |
|
564
Old Second Bancorp
OSBC
$1.3B
| $1.9M | ﹤0.01% |
97,285
-5,220
| -5% | -$97.5K |
|
565
Hormel Foods
HRL
$13.8B
| $1.88M | ﹤0.01% |
79,493
+22,558
| +40% | +$527K |
|
566
CNB Financial Corp
CCNE
$1.03B
| $1.87M | ﹤0.01% |
71,344
-3,831
| -5% | -$97.2K |
|
567
Gorman-Rupp
GRC
$2.21B
| $1.86M | ﹤0.01% |
38,916
-4,204
| -10% | -$196K |
|
568
American Public Education
APEI
$940M
| $1.85M | ﹤0.01% |
48,988
-2,744
| -5% | -$98.2K |
|
569
NextEra Energy
NEE
$177B
| $1.83M | ﹤0.01% |
22,822
+2,064
| +10% | +$171K |
|
570
Oppenheimer Holdings
OPY
$1.2B
| $1.83M | ﹤0.01% |
25,286
-1,378
| -5% | -$95.9K |
|
571
Stepan Co
SCL
$1.48B
| $1.82M | ﹤0.01% |
38,365
+5
| +0% | +$229 |
|
572
National Grid
NGG
$81.3B
| $1.81M | ﹤0.01% |
23,418
-37
| -0.2% | -$2.78K |
|
573
Vanguard Total International Stock ETF
VXUS
$160B
| $1.81M | ﹤0.01% |
24,005
-25,276
| -51% | -$1.89M |
|
574
Zymeworks
ZYME
$1.73B
| $1.8M | ﹤0.01% |
68,197
-3,777
| -5% | -$82.4K |
|
|
DAWN
575
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.79M | ﹤0.01% |
191,823
-28,340
| -13% | -$237K |
|
Similar funds
Ken Fisher's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Fisher held 1,126 positions worth $293B, up 6% from $276B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Fisher's Q4 2025 filing shows 112 new, 480 increased, 403 reduced and 109 closed positions. Its largest new stake was Belden: 369,776 shares worth $43.1M. The largest sale was iShares MBS ETF, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2025 buy was Belden: 369,776 shares worth $43.1M.
- Ken Fisher added most to iShares 7-10 Year Treasury Bond ETF in Q4 2025, an estimated $4.56B increase.
- Ken Fisher's biggest Q4 2025 reduction was iShares MBS ETF, cutting an estimated $2.05B.
- Ken Fisher fully exited Infosys in Q4 2025, selling an estimated $146M.
- Ken Fisher's ten largest holdings make up 34% of its $293B portfolio in Q4 2025.
- Ken Fisher opened 112 new positions and closed 109 in Q4 2025.
- Ken Fisher's portfolio value rose 6% quarter-over-quarter to $293B.
Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.